You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 54 No. 1, January 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Natural Course of Cerebral Lesions in Sneddon Syndrome

Ayman Tourbah, MD, PhD; Jean Charles Piette, MD; Marie T. Iba-Zizen, MD; Olivier Lyon-Caen, MD; Pierre Godeau, MD; Camille Francès, MD

Arch Neurol. 1997;54(1):53-60.


Abstract

Objectives
To characterize the clinical, biological, and neuroradiological findings in Sneddon syndrome; to correlate magnetic resonance imaging abnormalities with disability, presence of hypertension and other vascular risk factors, presence of heart valvulopathy on echography, and titer of antiphospholipid antibodies; and to compare these findings in antiphospholipid-positive and antiphospholipid-negative patients.

Design
Retrospective review of the records of 32 consecutive patients with livedo reticularis and neurological events, followed up in our institution between January 1991 and August 1995.

Patients
Twenty-six patients (20 women and 6 men) who had at least 1 cerebral ischemic arterial event associated with generalized and pathological livedo reticularis.

Results
The age at the first cerebral ischemic event ranged from 22 to 58 years. Motor deficit was the most frequent sign (found in 73% of cases). Disability was found in 50%, systemic hypertension in 65%, heart valvulopathy in 61%, and antiphospholipid antibodies in 42% of cases. Patients were classified in 6 groups according to magnetic resonance imaging findings. No correlation was found between the presence of hypertension or other vascular risk factors, valvulopathy, antiphospholipids, and magnetic resonance imaging abnormalities. There was no significant difference between antiphospholipid-positive and antiphospholipid-negative patients except for the presence of antinuclear antibodies. There was a significant correlation between the extent of magnetic resonance imaging abnormalities and disability.

Conclusion
The severity of the disease seems to be correlated with magnetic resonance imaging aspects, but not to the presence of antiphospholipid antibodies. Magnetic resonance imaging may help to understand the natural course of the cerebral involvement of the disease.



Author Affiliations

From the Fédération de Neurologie (Drs Tourbah and Lyon-Caen), Service de Médecine Interne (Drs Piette, Godeau, and Francès), Groupe Hospitalier Pitié-Salpêtrière, and Service de Neuroradiologie, CNO des 15-20, Paris, France.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Congenital Livedo Reticularis and Recurrent Strokes in Two Unrelated Young Children
Mathias et al.
CLIN PEDIATR 2006;45:367-372.
 

Sneddon's Syndrome: Another Migraine-Stroke Association?
Tietjen et al.
Cephalalgia 2006;26:225-232.
ABSTRACT | FULL TEXT  

Dementia associated with antiphospholipid antibodies
Adair
Rheumatology (Oxford) 2006;45:241-242.
FULL TEXT  

The natural course of Sneddon syndrome: clinical and magnetic resonance imaging findings in a prospective six year observation study
Boesch et al.
J. Neurol. Neurosurg. Psychiatry 2003;74:542-544.
ABSTRACT | FULL TEXT  

IDENTIFICATION AND MANAGEMENT OF DIFFICULT STROKE AND TIA SYNDROMES
Brown
J. Neurol. Neurosurg. Psychiatry 2001;70:17i-22.
FULL TEXT  

Effects of antithrombin on Binswanger's disease with antiphospholipid antibody syndrome
Akiguchi et al.
Neurology 1999;52:398-398.
ABSTRACT | FULL TEXT  

Review : Neurological manifestations of antiphospholipid antibody syndrome
Brey and Escalante
Lupus 1998;7:S67-S74.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.